文献速递其他结缔组织病

抗HMGCR自身抗体与幼年肌炎DRB1*07:01及严重肌病相关

Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2017-01-01

该研究筛查440例幼年肌炎患者血清中的抗HMGCR自身抗体,发现5例(1.1%)阳性且均未使用他汀类药物。这些患者均携带HLA-DRB1*07:01,表现为严重近端与远端肌无力、肌萎缩、关节挛缩和关节痛,CK中位最高值达17,000 IU/liter,对多种免疫抑制治疗仅部分应答,病程常呈慢性。

要点

  • 抗HMGCR阳性幼年肌炎患者均无他汀暴露史,与成人不同。
  • 5例抗HMGCR阳性患者全部携带DRB1*07:01,无一携带DRB1*11:01。
  • 抗HMGCR阳性者肌病更重、CK更高,且对免疫抑制治疗仅部分应答。

核心结论

  • 与携带其他肌炎特异性自身抗体的儿童相比,抗HMGCR自身抗体阳性儿童的肌肉病变似乎更严重。
  • 与成人相似,抗HMGCR阳性儿童存在严重肌无力和高CK水平;与成人不同,其与HLA-DRB1*07:01强关联。

研究设计与样本

  • 研究筛查了440例幼年肌炎患者的血清以检测抗HMGCR自身抗体,并评估人口学与临床特征、治疗应答及HLA等位基因。
  • 将抗HMGCR阳性患者特征与既往描述的成人抗HMGCR阳性患者及携带其他肌炎特异性自身抗体的儿童进行比较。

主要发现

  • 440例中5例(1.1%)抗HMGCR阳性,均未服用他汀类药物。
  • 3例有幼年皮肌炎特征性皮疹,2例为免疫介导的坏死性肌病。
  • 抗HMGCR阳性者最高CK中位水平为17,000 IU/liter。
  • 所有抗HMGCR阳性患者均有严重近端肌无力、远端无力、肌萎缩、关节挛缩和关节痛,且这些表现较MSA阴性或其他MSA阳性患者更常见。
  • 抗HMGCR阳性患者对多种免疫抑制药物仅部分应答,疾病常呈慢性病程。

关键数值与推荐

  • 5例抗HMGCR阳性患者均携带DRB1*07:01等位基因,健康对照中该等位基因频率为26.25%(校正P=0.01)。
  • 5例幼年患者中无一携带DRB1*11:01。

临床怎么用

  • 对幼年肌炎患者检测抗HMGCR自身抗体有助于识别肌病更重、CK更高且治疗应答不完全的亚群。
  • 抗HMGCR阳性幼年患者即使无他汀暴露史也应考虑该抗体,并关注HLA-DRB1*07:01。
  • 此类患者需警惕慢性病程,治疗上宜早期积极多药联合并长期随访。

局限性

  • 抗HMGCR阳性患者仅5例,样本量小,结论需更大队列验证。
  • 为横断面血清筛查与特征分析,治疗应答与病程描述基于小样本观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Autoantibodies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) are associated with statin exposure, the HLA allele DRB1*11:01, and necrotizing muscle biopsies in adult myositis patients. The aim of this study was to characterize the features of juvenile anti-HMGCR-positive myositis patients. METHODS: The sera of 440 juvenile myositis patients were screened for anti-HMGCR autoantibodies. Demographic and clinical features, responses to therapy, and HLA alleles were assessed. The features of anti-HMGCR-positive patients were compared to those of previously described adult patients with this autoantibody and to children with other myositis-specific autoantibodies (MSAs). RESULTS: Five of 440 patients (1.1%) were anti-HMGCR-positive; none had taken statin medications. Three patients had rashes characteristic of juvenile dermatomyositis and 2 patients had immune-mediated necrotizing myopathies. The median highest creatine kinase (CK) level of anti-HMGCR-positive subjects was 17,000 IU/liter. All patients had severe proximal muscle weakness, distal weakness, muscle atrophy, joint contractures, and arthralgias, which were all more prevalent in HMGCR-positive subjects compared to MSA-negative patients or those with other MSAs. Anti-HMGCR-positive patients had only partial responses to multiple immunosuppressive medications, and their disease often took a chronic course. The DRB1*07:01 allele was present in all 5 patients, compared to 26.25% of healthy controls (corrected P = 0.01); none of the 5 juvenile patients had DRB1*11:01. CONCLUSION: Compared to children with other MSAs, muscle disease appears to be more severe in those with anti-HMGCR autoantibodies. Like adults, children with anti-HMGCR autoantibodies have severe weakness and high CK levels. In contrast to adults, in anti-HMGCR-positive children, there is a strong association with HLA-DRB1*07:01.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Kishi T, Rider LG, Pak K, et al. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients. Arthritis Care Res (Hoboken). 2017. PMID: 28129483. doi:10.1002/acr.23113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。